A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

I4X-MC-JFCP -

The purpose of the study is to determine if nab-paclitaxel and carboplatin chemotherapy plus necitumumab is effective and safe in participants with stage IV squamous non-small cell lung cancer.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Lung Cancer
What the trial is testing?
Nab-paclitaxel, Necitumumab, Carboplatin
Could I receive a Placebo?
No
Enrollment Goal
54
Trial Dates
Oct 12, 2015 - Nov 6, 2019
How long will I be in the trial?
You can participate in this study for as long as your study doctor determines that you are benefiting from the study treatment.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.